Martek Announces Second Quarter 2009 Financi...( Diluted earnings ...),Health

Date:6/3/2009

====== ====== ====== ====== Diluted earnings per share $ 0.33 $ 0.28 $0.62 $0.54 ====== ====== ====== ====== Shares used in computing basic earnings per share 33,190 32,916 33,170 32,830 Shares used in computing diluted earnings per share 33,310 33,231 33,349 33,151

    Unaudited Condensed Consolidated Balance Sheets Data

                                                    April 30,  October 31,
                                                        2009         2008
                                                    --------    ---------

     Assets:
        Cash and cash equivalents                   $117,944     $102,495
        Accounts receivable, net                      52,898       40,438
        Inventories, net                             109,603       99,553
        Other current assets                           3,905        4,866
        Property, plant and equipment, net           259,747      265,900
        Deferred tax asset                            25,819       38,356
        Long-term investments                         11,615       11,336
        Goodwill and other, net                       84,029       83,037
                                                     -------      -------
     Total assets                                   $665,560     $645,981
                                                     =======      =======

     Liabilities and stockholders' equity:
        Current liabilities                          $43,420      $47,342
        Non-current liabilities                        9,301       10,056
        Stockholders' equity                         612,839      588,583
                                                     -------      -------
     Total liabilities and stockholders' equity     
'/>"/>
SOURCE  Martek Biosciences Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 
Related medicine news :

1. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
2. Martek Announces Third Quarter 2007 Financial Results
3. Martek Announces Addition of lifesDHA(TM) to Entire Bellybar(TM) Line of Nutrition Bars
4. Martek Signs Multi-Year Infant Formula License and Supply Agreement with Alter Farmacia
5. Marteks lifesDHA(TM) Featured in New Beech-Nut(R) DHA Plus Baby Food and Cereals
6. Martek Wins German DHA Patent Infringement Actions Against Lonza and One of Nutrinovas Customers in Suits Relating to DHA Product Marketed for Use in Functional Foods and Dietary Supplements
7. Martek Signs Exclusive Worldwide Distributorship Agreement with Novus International
8. Marteks lifesDHA(TM) Featured in Dalco Foods Wellness Line Meat Products
9. Martek Announces Settlement of Class Action Lawsuit
10. Pocket Rocket Juice from Australias Boost Juice Features 700 mg of Marteks lifesDHA(TM)
11. Summary Notice of Proposed Settlement and Settlement Hearing in Re Martek Biosciences Corp., Securities Litigation